FDA Holds Expert Panel on Talc Safety in Food & Drugs
FDA panel assesses talc safety in food and drug products
On May 20, 2025, the FDA convened an expert panel to evaluate the safety and necessity of talc as an additive in foods and pharmaceuticals, citing its Group 2A classification as a “probably carcinogenic” agent by IARC. Panel discussions emphasized the inflammation-related risks of talc ingestion and general use, suggesting industry should consider safer alternatives.
Categories
Related Posts
- FDA Reports Extensive Cosmetic Facility Registration & Product Listings (MoCRA Compliance)
- Health Canada Finalizes Version 4.0 of NHP GMP Guidance (Effective March 4, 2026)
- FDA Publicizes Interim Cosmetic Registration & Listing Data (March 2025)
- TIME Highlights Talc in the Spotlight Amid Safety Concerns
- FDA Proposes Standardized Asbestos Testing for Talc-Containing Cosmetics
